1-20 of 24
Authors: Roland Tubiana
Journal Article
Changes in NNRTI use have not altered the ecology of NNRTI resistance over the last 10 years in people with HIV experiencing virological failure on antiretroviral drugs Get access
Journal of Antimicrobial Chemotherapy, Volume 80, Issue 3, March 2025, Pages 697–700, https://doi.org/10.1093/jac/dkae458
Published: 20 December 2024
Journal Article
Maintenance darunavir/ritonavir monotherapy to prevent perinatal HIV transmission, ANRS-MIE 168 MONOGEST study
Journal of Antimicrobial Chemotherapy, Volume 78, Issue 7, July 2023, Pages 1711–1722, https://doi.org/10.1093/jac/dkad161
Published: 30 May 2023
Journal Article
HIV stigma limits the effectiveness of PMTCT in Guinea: the ANRS 12344-DIAVINA study
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 11, November 2022, Pages 3093–3101, https://doi.org/10.1093/jac/dkac287
Published: 29 August 2022
Journal Article
More HIV-1 RNA detected and quantified with the Cobas 6800 system in patients on antiretroviral therapy
Journal of Antimicrobial Chemotherapy, Volume 77, Issue 8, August 2022, Pages 2251–2256, https://doi.org/10.1093/jac/dkac174
Published: 31 May 2022
Journal Article
Presence of HIV-1 G-to-A mutations linked to APOBEC editing is more prevalent in non-B HIV-1 subtypes and is associated with lower HIV-1 reservoir
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 8, August 2021, Pages 2148–2152, https://doi.org/10.1093/jac/dkab123
Published: 30 April 2021
Journal Article
Intermittent two-drug antiretroviral therapies maintain long-term viral suppression in real life in highly experienced HIV-infected patients
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 7, July 2021, Pages 1893–1897, https://doi.org/10.1093/jac/dkab108
Published: 14 April 2021
Journal Article
No difference in HIV-1 integrase inhibitor resistance between CSF and blood compartments
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 6, June 2021, Pages 1553–1557, https://doi.org/10.1093/jac/dkab064
Published: 10 March 2021
Journal Article
Once-daily etravirine/raltegravir (400/800 mg q24h) dual therapy maintains viral suppression over 48 weeks in HIV-infected patients switching from a twice-daily etravirine/raltegravir (200/400 mg q12h) regimen
Journal of Antimicrobial Chemotherapy, Volume 76, Issue 2, February 2021, Pages 477–481, https://doi.org/10.1093/jac/dkaa423
Published: 25 October 2020
Journal Article
Rilpivirine in HIV-1-positive women initiating pregnancy: to switch or not to switch?
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1324–1331, https://doi.org/10.1093/jac/dkaa017
Published: 11 March 2020
Journal Article
Efficacy of intermittent short cycles of integrase inhibitor-based maintenance ART in virologically suppressed HIV patients
Journal of Antimicrobial Chemotherapy, Volume 75, Issue 5, May 2020, Pages 1321–1323, https://doi.org/10.1093/jac/dkz555
Published: 16 January 2020
Journal Article
Antiretroviral drug reduction in highly experienced HIV-infected patients receiving a multidrug regimen: the ECOVIR study
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 9, September 2019, Pages 2716–2722, https://doi.org/10.1093/jac/dkz255
Published: 04 July 2019
Journal Article
Plasma cystatin C as a marker for estimated glomerular filtration rate assessment in HIV-1-infected patients treated with dolutegravir-based ART
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 7, July 2018, Pages 1935–1939, https://doi.org/10.1093/jac/dky112
Published: 24 April 2018
Journal Article
Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients
Journal of Antimicrobial Chemotherapy, Volume 73, Issue 5, May 2018, Pages 1173–1176, https://doi.org/10.1093/jac/dkx530
Published: 03 February 2018
Journal Article
APOL1 variants may induce HIV-associated nephropathy during HIV primary infection
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 5, May 2017, Pages 1539–1541, https://doi.org/10.1093/jac/dkw563
Published: 18 January 2017
Journal Article
HIV-1 diagnosis with unquantifiable viraemia: don’t be naive, look for antiretroviral drugs
Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 630–632, https://doi.org/10.1093/jac/dkw474
Published: 20 December 2016
Journal Article
Low-level HIV-1 viraemia in patients on HAART: risk factors and management in clinical practice Get access
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 8, August 2015, Pages 2347–2353, https://doi.org/10.1093/jac/dkv099
Published: 28 April 2015
Journal Article
Very early ART resulting in the absence of HIV-1 antibodies and in a sustained undetectable plasma HIV-1-RNA and proviral-DNA in an HLA-B*5701 and Δ32 heterozygote HIV-1-infected patient was not associated with functional cure Get access
Journal of Antimicrobial Chemotherapy, Volume 70, Issue 1, January 2015, Pages 317–319, https://doi.org/10.1093/jac/dku370
Published: 19 September 2014
Journal Article
Factors associated with a low HIV reservoir in patients with prolonged suppressive antiretroviral therapy Get access
Journal of Antimicrobial Chemotherapy, Volume 69, Issue 3, March 2014, Pages 753–756, https://doi.org/10.1093/jac/dkt428
Published: 01 November 2013
Journal Article
Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies Get access
Journal of Antimicrobial Chemotherapy, Volume 68, Issue 12, December 2013, Pages 2882–2889, https://doi.org/10.1093/jac/dkt272
Published: 19 July 2013
Journal Article
Pitfalls of HIV genotypic tropism testing after treatment interruption Get access
Journal of Antimicrobial Chemotherapy, Volume 68, Issue 1, January 2013, Pages 188–189, https://doi.org/10.1093/jac/dks362
Published: 06 September 2012
